Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial
13 mars 2025 09h15 HE
|
BioAdaptives Inc.
LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product, Zeranovia™....
PatchMD Introduces New GLP-1 Support Patches for Individuals on Weight Loss Medications
12 mars 2025 06h45 HE
|
PatchMD
HENDERSON, NV, March 12, 2025 (GLOBE NEWSWIRE) -- PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support Patch Collection—a...
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
10 mars 2025 08h00 HE
|
PMGC Holdings Inc.
Northstrive Biosciences, Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination
Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination
05 mars 2025 15h20 HE
|
Natural Alternatives International Inc
Published clinical study demonstrated TriBsyn™ led to significantly greater bioavailability & efficiency of beta-alanine and the elimination of paresthesia
Ideal Protein Launches Whitepaper Unveiling Synergistic Approach to Enhance GLP-1 Medication Outcomes
27 févr. 2025 14h19 HE
|
Ideal Protein
New resource highlights critical role of lifestyle interventions in maximizing weight loss success and addressing limitations of GLP-1 therapies.
How GLP-1 Drugs Are Reshaping the $33.8 Billion U.S. Medical Weight Loss Industry
27 févr. 2025 09h42 HE
|
Research and Markets
Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "U.S. Medical Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering. This report presents a complete...
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market
26 févr. 2025 08h30 HE
|
PMGC Holdings Inc.
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists
18 févr. 2025 07h00 HE
|
PMGC Holdings Inc.
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Pre-Investigational New Drug Meeting Submission Request to U.S. Food and Drug A
NASM Launches New Understanding Weight Loss Medications Course
11 févr. 2025 07h00 HE
|
The National Academy of Sports Medicine
Gilbert, AZ, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The National Academy of Sports Medicine® (NASM), the global leader in fitness and wellness training and certifications, is launching its latest course,...
AquaSculpt Publishes Full Natural Ingredients List to Offer Customers Full Transparency and Confidence
05 févr. 2025 08h00 HE
|
AquaSculpt
New York, NY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- AquaSculpt, a natural weight loss option that combines a unique formulation with a novel approach known as the Ice Water Hack, is happy to announce...